MEDIZONE INTERNATIONAL, INC. (OTCMKTS:MZEI) Files An 8-K Regulation FD DisclosureItem 7.01 Regulation FD Disclosure.
On March 27, 2018, the Company posted a “Shareholder Update” to its corporate website at www.medizoneint.com. The text of the update is attached as Exhibit 99.1.
Item 9.01. Financing Statements and Exhibits.
(d)Exhibits
|
99.1 |
Shareholder Update dated March 27, 2018.
|
MEDIZONE INTERNATIONAL INC ExhibitEX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Shareholder Update 3-27-2018 Dear fellow shareholders,…To view the full exhibit click here
About MEDIZONE INTERNATIONAL, INC. (OTCMKTS:MZEI)
Medizone International, Inc. is engaged in designing, manufacturing and selling a system using ozone in the disinfection of surgical and other medical treatment facilities and in other applications. The Company’s AsepticSure is an ozone-based technology, which is used for the purpose of decontaminating and disinfecting hospital surgical suites, emergency rooms, intensive care units and other enclosed spaces, such as gym locker rooms, laboratories and veterinary clinics. In the AsepticSure system, oxygen atoms are misted into the environment with a hydrogen peroxide vapor and the system’s formula creates Trioxidane. The Company is developing a variant of AsepticSure for governmental use with bio-terrorism countermeasures. AsepticSure has completed safety and preliminary operational trials. During the tests, AsepticSure has demonstrated a turnaround time of approximately 90 minutes for disinfection and reoccupation of the hospital rooms.
